TRIM72 | Tripartite motif containing 72 | | | | | | Tissue enriched |
AMPD1 | Adenosine monophosphate deaminase 1 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
APOBEC2 | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2 | | | | | | Group enriched |
ARPP21 | CAMP-regulated phosphoprotein, 21kDa | | | | | | Group enriched |
FHL3 | Four and a half LIM domains 3 | | | | | | Tissue enriched |
LDB3 | LIM domain binding 3 | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Group enriched |
MYOM1 | Myomesin 1 | | | | | | Group enriched |
MYOM2 | Myomesin 2 | | | | | | Group enriched |
PPP1R3A | Protein phosphatase 1, regulatory subunit 3A | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
RBFOX1 | RNA binding protein, fox-1 homolog (C. elegans) 1 | | | | | | Group enriched |
XIRP1 | Xin actin-binding repeat containing 1 | | | | | | Group enriched |
ANKRD2 | Ankyrin repeat domain 2 (stretch responsive muscle) | | | | | | Group enriched |
ASB18 | Ankyrin repeat and SOCS box containing 18 | Predicted membrane proteins
| | | | | Group enriched |
CA3 | Carbonic anhydrase III, muscle specific | Enzymes FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
CACNG6 | Calcium channel, voltage-dependent, gamma subunit 6 | Predicted membrane proteins Transporters
| | | | | Group enriched |
HSPB3 | Heat shock 27kDa protein 3 | Disease related genes
| | | | | Group enriched |
LRRC30 | Leucine rich repeat containing 30 | | | | | | Tissue enriched |
MYF6 | Myogenic factor 6 (herculin) | Disease related genes Transcription factors
| | | | | Tissue enriched |
NRAP | Nebulin-related anchoring protein | Plasma proteins
| | | | | Group enriched |
TCAP | Titin-cap | Disease related genes
| | | | | Group enriched |
TMEM233 | Transmembrane protein 233 | Predicted membrane proteins
| | | | | Group enriched |
TMEM38A | Transmembrane protein 38A | Predicted membrane proteins
| | | | | Tissue enriched |
VGLL2 | Vestigial like 2 (Drosophila) | | | | | | Tissue enriched |
ASB11 | Ankyrin repeat and SOCS box containing 11 | Predicted membrane proteins
| | | | | Group enriched |
ASB16 | Ankyrin repeat and SOCS box containing 16 | | | | | | Tissue enriched |
CAMK2A | Calcium/calmodulin-dependent protein kinase II alpha | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
KLHL34 | Kelch-like family member 34 | | | | | | Tissue enriched |
KLHL40 | Kelch-like family member 40 | Disease related genes
| | | | | Tissue enriched |
MSS51 | MSS51 mitochondrial translational activator | | | | | | Tissue enriched |
MYOZ3 | Myozenin 3 | | | | | | Tissue enriched |
TNNC1 | Troponin C type 1 (slow) | Disease related genes FDA approved drug targets Plasma proteins
| | | | | Group enriched |
CALML6 | Calmodulin-like 6 | RAS pathway related proteins
| | | | | Tissue enriched |
PPAPDC3 | Phosphatidic acid phosphatase type 2 domain containing 3 | Predicted membrane proteins
| | | | | Group enriched |
TBX15 | T-box 15 | Disease related genes Transcription factors
| | | | | Group enriched |
ABRA | Actin-binding Rho activating protein | | | | | | Group enriched |
ATP1B4 | ATPase, Na+/K+ transporting, beta 4 polypeptide | Predicted membrane proteins
| | | | | Tissue enriched |
ENO3 | Enolase 3 (beta, muscle) | Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enriched |
LSMEM1 | Leucine-rich single-pass membrane protein 1 | Predicted membrane proteins
| | | | | Tissue enriched |
MB | Myoglobin | Candidate cardiovascular disease genes Plasma proteins
| | | | | Group enriched |
MUSTN1 | Musculoskeletal, embryonic nuclear protein 1 | | | | | | Tissue enriched |
MYL3 | Myosin, light chain 3, alkali; ventricular, skeletal, slow | Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | | | | Group enriched |
PDE4DIP | Phosphodiesterase 4D interacting protein | Cancer-related genes Disease related genes
| | | | | Group enriched |
PGAM2 | Phosphoglycerate mutase 2 (muscle) | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
PHKG1 | Phosphorylase kinase, gamma 1 (muscle) | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
SLC25A4 | Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 | Disease related genes FDA approved drug targets Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
SLN | Sarcolipin | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
TMEM182 | Transmembrane protein 182 | Predicted membrane proteins
| | | | | Group enriched |
TNNT1 | Troponin T type 1 (skeletal, slow) | Disease related genes
| | | | | Tissue enriched |
ASB10 | Ankyrin repeat and SOCS box containing 10 | Disease related genes
| | | | | Tissue enriched |
FABP3 | Fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor) | Candidate cardiovascular disease genes Plasma proteins
| | | | | Group enriched |